v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
CASH FLOW FROM OPERATING ACTIVITIES:    
Net loss $ (205,037) $ (736,545)
Adjustments to reconcile net loss to net cash used for operating activities:    
Depreciation 14,716 21,782
Amortization of intangible assets 56,039 76,245
Amortization of capitalized contract costs 40,000 46,545
Amortization of note payable 20,833 60,000
Interest payable on note 27,000 35,173
Reserve for inventory (98,970) 0
Operating leases right-of-use assets 6,570 6,230
Share and warrant-based compensation for employees and consultants 40,744 52,488
Stock based directors’ fees 0 9,002
Bad debts 0 15,000
Change in operating assets and liabilities:    
Accounts receivable (352,632) (85,048)
Due from factor 0 33,720
Capitalized contract costs (22,824) (12,824)
Inventory 131,452 20,465
Prepaid expenses and other (74,720) 24,363
Accounts payable 2,074 (259,571)
Accrued liabilities (206,831) (236,321)
Deferred revenue 265,404 95,718
Operating lease liabilities (1,819) (1,734)
Net cash used in operating activities (358,001) (835,312)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Capital expenditures 0 (4,570)
Net cash used in investing activities 0 (4,570)
CASH FLOW FROM FINANCING ACTIVITIES:    
Offering costs 0 (248,783)
Proceeds for exercise of warrants 0 3,813,057
Repayment of government loan (38,179) (35,047)
Net cash used in financing activities (38,179) 3,529,227
Effect of exchange rate changes (50,499) 6,803
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (446,679) 2,696,148
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD 2,694,663 437,604
CASH AND CASH EQUIVALENTS, END OF PERIOD 2,247,984 3,133,752
Cash paid for:    
Interest 675 737
Noncash investing and financing activities    
Issuance of stock for repayment of debt $ 0 $ 859,000